Anika Therapeutics ANIK Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Commercial Channel | $13.91M+17.1% | $12.58M+11.7% | $13.3M+21.7% | $11.97M+22.2% | $11.88M+0.4% | |
| OEM Channel | $18.71M+14.5% | $17.04M+14.3% | $17.31M-12.0% | $15.84M-19.8% | $16.34M-13.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Anika Therapeutics break its business down?
- Anika Therapeutics (ANIK) reports revenue by product across 2 parts — Commercial Channel and OEM Channel. Each is extracted from the segment footnotes and tracked over time.
- Where does Anika Therapeutics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Anika Therapeutics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
